Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Convergence starts operations with two GSK candidates

Executive Summary

Several months after deciding to discontinue discovery research in pain and depression indications, GlaxoSmithKline PLC has sold a group of pain compounds to just-launched Convergence Pharmaceuticals Ltd. The deal includes voltage-gated ion channel inhibitors and related IP.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • R+D and Marketing-Licensing
    • Reverse Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register